Academic Solutions to Cost Containment, Financial Toxicity

At the Society of Urologic Oncology Annual Meeting, Daniel Joyce, MD, Vanderbilt University Medical Center, and Christopher Wallis, MD, PhD, FRCSC, University of Toronto, consider the impact of financial toxicity for patients with genitourinary malignancies.

They also opine on meaningful ways to synthesize and weigh the positive results of recent clinical trials against the cost of therapy when counseling patients.